Zydus Lifesciences and Sunshine Healthcare Lanka Announce Strategic Joint Venture in Sri Lanka

Date:

Share post:

Zydus Lifesciences Ltd., a leading global lifeciences company, and Sunshine Healthcare Lanka Ltd. (SHL), a premier healthcare marketing and distribution firm, have officially exchanged a definitive agreement to establish a strategic joint venture company, Zydus Sunshine Lifesciences Ltd. 

The new entity marks a significant milestone in expanding advanced healthcare access across Sri Lanka. By leveraging Zydus Lifesciences’ extensive global product portfolio, robust research capabilities, and manufacturing excellence alongside Sunshine Healthcare Lanka’s deep market penetration, countrywide distribution infrastructure, and localized commercial expertise, the partnership aims to bring high-quality, innovative, and affordable therapeutic solutions to Sri Lankan patients.

Dr. T. Sayandhan announced the collaboration, noting that the joint venture will focus on bridging critical gaps in the country’s current healthcare system by introducing specialized formulations across multiple key therapeutic segments. This long-term synergy highlights both companies’ mutual commitment to transforming patient outcomes and driving sustainable growth in the South Asian pharmaceutical sector.

Operations for Zydus Sunshine Lifesciences Ltd. will commence immediately under a joint management structure.

Written by: Pragna Biswas

Graphics by: Pramit Hazra

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related articles

MSD Inaugurates New Technology Centre in Hyderabad to Drive Global Healthcare Innovation and Digital Capabilities

MSD (Merck & Co., Inc.), one of the world's leading global life sciences companies, has officially inaugurated its...

Bharat Technology Announces BT-PHARMACON 2K26 with Focus on Indigenous Pharma Innovation

Bharat Technology is set to organise BT-PHARMACON 2K26, an ANRF-sponsored national conference on September 26–27, 2026, at the Eastern Zonal...

ChrysCapital to Acquire 20-25% Stake in Linux Laboratories for ₹600 Crore

Private equity firm ChrysCapital is all set to acquire a strategic stake in Linux Laboratories, a Chennai-based specialty pharmaceutical company focused on central nervous...

India Spotlights Massive Health Workforce Expansion at WHO RC79; SEARO Adopts Historic Dili Declaration

The Ministerial Roundtable addressing on"Human Resources for Health: Equity in Specialized Care" at the 79th Session of the WHO Regional...